News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.50d agoneutral
Is Recursion Pharmaceuticals (RXRX) A Bargain As Its Shares Rebound?MT Newswires83d agoneutral
Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley SaysMarketBeat83d agoneutral
Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline UpdatesSimply Wall St.95d agoneutral
Recursion Pharmaceuticals (RXRX) Is Up 11.4% After Mixed Q2 Results And Genentech Milestone UpdateSimply Wall St.95d agoneutral
Recursion Pharmaceuticals (RXRX) Stock Still Looks Expensive Following August 5 Results UpdateMotley Fool117d agobullish
Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?Insider Monkey122d agoneutral
Is Recursion Pharmaceuticals (RXRX) The Best Penny Stocks According to Billioanires?Simply Wall St.126d agoneutral
Recursion Pharmaceuticals (RXRX) Stock Looks Fully Valued Despite AI Drug HopesMotley Fool126d agoneutral
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought